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Abstract
Introduction—Healthcare personnel (HCP) are at risk for pertussis infection exposure or 
transmitting the disease to patients in their work settings. The Advisory Committee on 
Immunization Practices recommends tetanus toxoid, reduced diphtheria toxoid, and acellular 
pertussis (Tdap) vaccination for HCP to minimize these risks. This study assessed Tdap 
vaccination coverage among U.S. HCP by sociodemographic and occupation-related 
characteristics.
Methods—The 2012, 2013, and 2014 Internet Panel Surveys were analyzed in 2015 to assess 
HCP Tdap vaccination. Effective sample sizes for 2012, 2013, and 2014 survey years were 2,038, 
1613, and 1633, respectively. Missing values were assigned using multiple imputation. 
Multivariable logistic regression identified factors independently associated with HCP Tdap 
vaccination. Statistical measures were calculated with an assumption of random sampling.
Results—Overall, Tdap vaccination coverage among HCP was 34.8% (95% CI=30.6%, 39.0%); 
40.2% (95% CI=36.1%, 44.4%); and 42.4% (95% CI=38.7%, 46.0%) in 2012, 2013, and 2014, 
respectively. Nurse practitioners/physician’s assistants, physicians, nurses, and HCP working in 
hospitals and ambulatory care settings had higher Tdap coverage. Having contact with an infant 
aged ≤6 months and influenza vaccination receipt were associated with increased Tdap 
vaccination. Non-Hispanic black race/ethnicity, having an associate/bachelor’s degree, being 
below poverty, non-clinical personnel status, and working in a long-term care setting were 
associated with decreased Tdap vaccination.
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Conclusions—HCP Tdap vaccination coverage increased during 2012–2014; however, coverage 
remains low. Vaccination coverage varied widely by healthcare occupation, occupational setting, 
and sociodemographic characteristics. Evidence-based employer strategies used to increase HCP 
influenza vaccination, if applied to Tdap, may increase Tdap coverage.
INTRODUCTION
Healthcare personnel (HCP) are at risk for exposure to and possible transmission of 
pertussis, a vaccine-preventable disease, in their occupational settings because of their 
contact with patients or respiratory secretions from patients.1–3 In several pertussis 
outbreaks in healthcare settings, HCP have been exposed to pertussis by other HCP, patients, 
and hospital visitors.4–8 Vaccinating HCP is one of the main strategies to protect them and 
prevent transmission of pertussis.9,10 The risk of pertussis among HCP is 1.7 times higher 
than that of the general adult population.11 To prevent pertussis in healthcare settings, the 
Advisory Committee on Immunization Practices recommended in 2005 that HCP aged <65 
years receive a single dose of tetanus toxoid, reduced diphtheria toxoid, and acellular 
pertussis (Tdap) vaccine at an interval as short as 2 years from the last dose of tetanus and 
diphtheria toxoids (Td).12 In 2011, the Advisory Committee on Immunization Practices 
revised and expanded the HCP Tdap recommendations to all HCP, regardless of age and 
time since their most recent Td vaccination.1 Hospital-based Tdap uptake among HCP has 
depended on the institution’s Tdap vaccination program; coverage rates range from 30% 
(campaign) to 100% (hospital mandate).13,14 Recent nationally reported Tdap coverage 
among HCP is 42.1%.15
Studies regarding Tdap vaccination among HCP have reported on overall coverage and 
coverage by occupation,15–18 with limited reports of Tdap vaccination among HCP by 
occupational setting.19 The objective of this study was to assess Tdap vaccination coverage 
and identify factors independently associated with vaccination among HCP by 
sociodemographic and employment factors, including occupation and occupational setting.
METHODS
Study Sample
The 2012, 2013, and 2014 Internet Panel Survey data were analyzed in 2015. The Internet 
Panel Survey is an opt-in web-based non-probability survey conducted by Abt Associates 
Inc. for the Centers for Disease Control and Prevention (CDC), which collects health 
information on the U.S. HCP population. HCP were eligible for the surveys if they reported 
working in a healthcare setting or having any patient contact.
Professional HCP (physicians, physician assistants [PAs], nurse practitioners [NPs], nurses, 
dentists, pharmacists, allied health professionals, technicians, and technologists) were 
recruited from the current membership roster of Medscape, a medical website managed by 
WebMD Health Professional Network. Individuals in additional HCP occupations 
(assistants, aides, administrators, clerical support workers, janitors, food service workers, 
and housekeepers) were recruited for a health survey from SurveySpot, a general population 
Internet panel that provides members with online survey opportunities in exchange for 
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nominal incentives. The same methodology was used in all 3 survey years. Among eligible 
respondents who started the survey, the survey completion rate was 93.2%, 95.5%, and 
94.9% for 2012, 2013, and 2014 surveys, respectively.
Measures
This study assessed Tdap vaccination. To determine Tdap vaccination status, respondents 
were asked the following question: Have you received a tetanus vaccine in the past 10 years? 
An affirmative answer to the tetanus vaccination question prompted a second question about 
the recency of the tetanus vaccination: Was your most recent tetanus vaccine given in 2005 
or later? An affirmative answer to this question prompted a question about the type of 
tetanus vaccination: Thinking back to your most recent tetanus vaccination, which vaccine 
were you given, the Td or tetanus–diphtheria vaccine or the Tdap, also known as Adacel™ 
or Boostrix™ (which includes the pertussis or whooping cough vaccine)?
Statistical Analysis
Point estimates and 95% CIs of vaccination coverage were calculated using SAS, version 
9.3, and SUDAAN, version 11.01. Data were weighted by age, sex, race/ethnicity, 
occupational setting, and Census region based on each occupation type to reflect the U.S. 
HCP population. Two-tailed chi-square tests were used to check for associations with 
significance level set at p < 0.05. Multivariable logistic and predictive marginal models were 
conducted to derive adjusted vaccination coverage and prevalence ratios to identify factors 
independently associated with Tdap vaccination. Poverty status was defined based on the 
reported number of people and children living in the household and annual household 
income, and the U.S. Census poverty thresholds (www.census.gov/data/tables/time-series/
demo/income-poverty/historical-poverty-thresholds.html). Statistical measures were 
calculated with an assumption of random sampling and should be interpreted only as guides 
to assessing the associations from this non-probability sample.
Missing data for Tdap vaccination status for respondents who answered that they were 
vaccinated with tetanus vaccine since 2005 but either were not told by their doctor or were 
not sure which type of tetanus vaccine they received were imputed using multiple imputation 
under the missing at random assumption.20 Details of item-level missingness of Tdap 
vaccination status in the cascade of questions used to ascertain the vaccination status and the 
effective sample size for the study population (which excluded those respondents who were 
missing for questions Have you received a tetanus vaccine in the past 10 years? and Was 
your most recent tetanus vaccine given in 2005 or later?) are presented in Table 1. Tdap 
vaccination status was imputed only for those missing the type of tetanus booster received 
(respondents who either were not told by their doctor the type of tetanus vaccine [Td or 
Tdap] they received or were not sure which type of tetanus vaccine they received) and the 
percentage of respondents with this missing data was 23.8%, 21.8%, and 26.3% for the 
2012, 2013, and 2014 surveys, respectively. Other variables with missing data, such as 
poverty, employment status, employer policy for influenza vaccination, age, contact with an 
infant aged ≤6 months, occupation, and occupational setting, were also imputed using this 
method. Estimates of Tdap vaccination were calculated with the multiply imputed data.
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Imputations were done using the logistic regression fractional conditional specification 
multiple imputation method.21 The SAS MI procedure was used to generate ten imputed 
data sets (relative efficiency rate, 97%).22 The results from the ten data sets were combined 
for overall inferences, accounting for variability between imputations by modifying the SAS 
macro procedure as described elsewhere.23
A sensitivity analysis was also conducted to assess the magnitude of potential recall bias by 
examining the impact of missing Tdap vaccination status on the overall Tdap coverage 
estimates. For the sensitivity calculations, all excluded respondents (those who answered my 
doctor did not say or not sure to the question about the type of the tetanus vaccination 
received) were assumed to be either not vaccinated or vaccinated with Tdap vaccination. 
Both pre- and post-imputation overall Tdap coverage estimates are reported. Proportions of 
HCP surveyed in 2012, 2013, and 2014 who reported receiving Tdap were estimated, and a 
test for linear trend by survey year was performed in SUDAAN using the RATIO procedure. 
Where not specifically mentioned, the results refer to estimates obtained post-imputation 
only. The Internet Panel Survey was designated as non-research by the review boards of 
CDC and Abt Associates Inc., and was exempt from IRB review.
RESULTS
A total of 2,353, 1,944, and 1,883 respondents from the 2012, 2013, and 2014 surveys, 
respectively, were included in the study. For primary analysis with imputed Tdap status, the 
effective sample sizes were 2,038, 1,613, and 1,633 for 2012, 2013, and 2014 surveys, 
respectively (Table 1).
The demographic characteristics of the samples and Tdap coverage by survey year are 
shown in Table 2. In all years, the largest proportions of HCP were aged 18–49 years, non-
Hispanic white, had associate/bachelor’s degree, were above poverty, worked as other 
clinical personnel, worked in a hospital, did not have contact with an infant aged ≤6 months, 
worked as a direct hire, and received influenza vaccination in the current influenza season 
(Table 2).
Pre-imputation Tdap coverage was 36.1% in 2012, 40.9% in 2013, and 44.3% in 2014 (data 
not shown). Tdap coverage post-imputation was 34.8% in 2012, 40.2% in 2013, and 42.4% 
in 2014 (Table 2). Overall, Tdap coverage among HCP increased from 34.8% in 2012 to 
42.4% in 2014 (test for trend, p=0.0031). In all survey years, coverage was higher among 
physicians, NPs/PAs, and nurses compared with other clinical personnel and non-clinical 
personnel (Table 2). By occupational group, the smallest increases in coverage from 2012 to 
2014 were observed among non-clinical personnel and other clinical personnel. The largest 
increase was seen among nurses, whose coverage increased from 48.1% in 2012 to 63.8% in 
2014 (Table 2), followed by NPs/PAs and physicians. In all survey years, coverage among 
HCP working in long-term care (LTC) settings was lower than among those working in 
hospitals or outpatient settings (Table 2). By occupational setting, the largest increase was 
observed within hospitals, where coverage increased from 35.7% in 2012 to 53.1% in 2014. 
Coverage remained stable from 2012 to 2014 among HCP working in ambulatory care 
settings (40.2% and 41.1% in 2012 and 2014, respectively) and LTC settings (20.9% and 
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22.9% in 2012 and 2014, respectively). Among HCP working in other healthcare settings, 
coverage decreased from 40.9% in 2012 to 30.9% in 2013, and then increased to 54.7% in 
2014 (Table 2).
Non-clinical personnel had a decreased likelihood of Tdap vaccination compared with 
physicians in all survey years, and working in an LTC setting was associated with decreased 
likelihood of vaccination in 2 survey years (Table 3). Factors associated with decreased 
likelihood of vaccination in at least 1 of 3 survey years included non-Hispanic black race/
ethnicity, having associate/bachelor’s degree, and living below poverty. Having contact with 
an infant aged ≤6 months was associated with increased likelihood of Tdap vaccination in 2 
survey years, and receipt of influenza vaccination was associated with increased likelihood 
of Tdap vaccination in 1 survey year (Table 3).
Sensitivity analyses varying proportions of respondents with missing Tdap vaccination 
status showed actual Tdap coverage could fall within the range of 25.9%–52.1% for 2012 
survey year, 30.1%–55.2% for 2013 survey year, and 31.7%–59.6% for 2014 survey year 
(Table 4).
DISCUSSION
In 2012, 2013, and 2014, Tdap vaccination coverage was 35%, 40%, and 42%, respectively. 
Coverage varied widely by occupation type, occupational setting, sociodemographic, and 
other employment-related characteristics. Though an increase in Tdap coverage over survey 
years was observed in this study, Tdap coverage among HCP remained low. Increasing Tdap 
vaccination among HCP is crucial to minimize risk of pertussis transmission in healthcare 
settings.
In 2012–2014, Tdap coverage increased in all occupational groups, with the smallest 
increase in coverage observed among other clinical and non-clinical personnel, groups that 
also had lower coverage. Overall Tdap coverage estimates among HCP in 2012 and 2014 
were similar to that reported from the nationally representative National Health Interview 
Survey (NHIS).15,17 Higher coverage was found among NPs/PAs, physicians, and nurses. 
The variability in Tdap coverage by HCP occupation type observed in this study was similar 
to variation in Tdap coverage by occupation type reported previously,19 but unlike 
differences in coverage observed between physicians, nurses, and other types of HCP in the 
NHIS study,19 coverage was similar among these occupation groups in this study. The 
estimates found in this study were higher compared with NHIS-estimated19 Tdap coverage 
among HCP. The higher point estimates in this study might be due to differences in sampling 
design, mode of the surveys, or other survey attributes. Although Tdap coverage among U.S. 
HCP remains suboptimal, yearly increases in coverage as observed in this study are 
nonetheless encouraging. Lower awareness of Tdap vaccine,24 lower intent among all HCP 
occupational groups to receive Tdap vaccine,25 and confusion about the interval to receive 
Tdap after receipt of the last Td vaccination19 have been reported as potential barriers to 
uptake of Tdap vaccination.
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This is the first report of Tdap coverage among HCP by occupational setting. By 
occupational setting, the lowest coverage was observed among HCP working in LTC settings 
and the highest coverage was found among HCP working in hospitals for all 3 years, similar 
to patterns in influenza vaccination among HCP by occupational setting.26 Higher coverage 
among HCP working in hospital settings could be attributable to policies requiring HCP to 
receive Tdap vaccination, such as making employment conditional upon receipt of Tdap 
vaccine for new employees and setting a termination date for noncompliance among current 
employees, policies that have been shown to increase vaccination levels.14 Approximately 
31% of U.S. hospitals had requirements for HCP to receive Tdap vaccine in 2011.27 
Although there were no estimates available for the frequency of requirements or other 
policies for Tdap vaccination in LTC settings, requirements for and promotion of influenza 
vaccination have been reported to be less common in LTC settings compared with 
hospitals.26 No increase in Tdap coverage was observed in LTC settings during the 3 years 
of the survey.
Characteristics associated with an increased likelihood of Tdap vaccination among HCP 
were having contact with an infant aged ≤6 months and receipt of influenza vaccination for 
the current season. Receipt of influenza vaccination in the previous season has been reported 
to be associated with increased Tdap vaccination among HCP19 and may suggest that 
strategies used to increase influenza vaccination among HCP could be beneficial in 
improving Tdap coverage. Despite Tdap vaccination being strongly recommended for HCP 
with any direct patient contact either in a hospital or clinic setting,1 intent to vaccinate and 
acceptance of pertussis vaccine18 and use of Tdap vaccines by HCP has been low,15,16,19 
and the implementation of immunization recommendations by healthcare institutions has 
been suboptimal.28 The association between having contact with an infant aged ≤6 months 
and increased likelihood of Tdap vaccination is likely due to the separate recommendation 
for Tdap vaccination as a cocooning strategy for prevention of pertussis in infants.29
Studies report that access to influenza vaccination at the worksite is associated with higher 
influenza coverage among HCP.30 Studies have also shown that HCP working in LTC 
settings were more likely to report that their employer neither required, provided, nor 
promoted influenza vaccination compared with HCP working in other occupational 
settings.26 In addition, HCP working in LTC settings have had the lowest reported influenza 
coverage compared with HCP working in other occupational settings.26,30 These findings 
indicate that employer support for worksite influenza vaccination activities is associated 
with higher likelihood that personnel will be vaccinated. Poor support of vaccination 
activities by LTC employers may help explain why a decreased likelihood of Tdap 
vaccination among HCP working in LTC settings was observed in the current study.
Another study using NHIS data reported that non-Hispanic black HCP with direct patient 
care responsibilities had lower Tdap coverage than non-Hispanic white HCP.15 A similar 
finding was reported in the current study, where non-Hispanic black HCP had decreased 
likelihood of Tdap vaccination. These findings suggest that racial/ethnic disparities still 
persist for routinely recommended vaccines, even among HCP. Racial/ethnic disparities in 
vaccination coverage among adults are multifactorial, involving patient-, provider-, and 
system-related factors, including differences in attitudes toward vaccination and preventive 
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care, propensity to seek or accept vaccination, differences by occupation and occupational 
settings, differences in the quality of care received by racial/ethnic minorities,15,31–35 and 
inconsistent adoption of the standards for adult vaccination practices.36
Though no studies have investigated strategies other than vaccination requirements to 
increase Tdap coverage, many studies have investigated the effects of employer policies in 
improving influenza coverage among HCP. Increasing awareness among HCP about the 
benefits of influenza vaccination with comprehensive employer vaccination programs such 
as convenient access to vaccination services and providing influenza vaccination at no 
charge1,37 have been shown to be associated with increased vaccination coverage. Similar 
policies implemented for Tdap vaccination may help improve Tdap coverage among HCP.
Limitations
The primary limitation of this study is the use of statistics with a non-probability sample—
estimates of sampling error are usually not computed.38 The sample was not randomly 
selected from the U.S. HCP population, but consisted of a nonprobability sample of 
volunteer HCP members of the Medscape and Survey-Spot Internet panels who self-selected 
to participate in these panels. Estimates of coverage may be biased if the selection processes 
for entry into the Internet panel and a survey participant’s decision to participate in the 
survey were related to receipt of vaccination. The statistical measures of association 
presented here should be taken only as a guide to assessing value of the associations from 
this non-probability sample. Overall Tdap coverage estimates among HCP in 2012 and 
2014, however, were similar to that reported from the nationally representative NHIS.15,17 
Second, the results based on these non-probability samples might not be representative of 
the U.S. HCP population as non-coverage and non-response bias may still remain even after 
weighting adjustments. Vaccination status was self-reported, not verified by employment or 
medical records, and might be subject to recall and misclassification bias. A recent study 
assessing the ability of healthcare workers to recall previous receipt of tetanus-containing 
vaccination and validating the self-report with their electronic medical record found high 
concordance between self-report and electronic medical record regarding their tetanus 
vaccination history within previous 2 years or more than 2 years earlier.39 However, in this 
study and in a previous study, even when HCP knew if they received a tetanus-containing 
vaccine, many did not know if it was Td or Tdap.19 Sensitivity analysis revealed that Tdap 
coverage estimates could have varied by approximately 20 percentage points depending on 
the number of excluded respondents with missing vaccination information that actually 
received Tdap. Finally, imputing for missing data may produce biased estimates, which 
depend upon the missingness pattern of the data and the analytic method used to impute 
missing data.40–42 Though it is impossible to know the actual reasons for all missing data, 
sensitivity analyses can provide a test of whether the assumptions of missing completely at 
random, missing at random, or missing not at random conditions are likely for a given set of 
analyses.42
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CONCLUSIONS
This study indicates that, despite Advisory Committee on Immunization Practices 
recommendations for Tdap vaccination since 2006 and availability of safe and effective 
vaccines, Tdap coverage among HCP remains low, particularly among other clinical and 
non-clinical personnel and HCP working in LTC settings. Comprehensive strategies by 
healthcare facilities are needed to increase overall vaccination coverage. Strategies that may 
help in improving uptake of Tdap vaccination and other recommended vaccinations for HCP 
include targeting intervention in areas where vaccination uptake is low; increasing awareness 
about potential effects of vaccination on overall HCP health, their patients, and their families 
along with the benefits of vaccination in reducing transmission of vaccine-preventable 
disease; providing vaccines at the workplace free or at reduced costs; and offering vaccines 
onsite or offsite, in clinics, or at multiple locations.1,37
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Table 3
Tdap Vaccination and Multivariable Logistic Regression Analysis Among Healthcare Personnel, by 
Sociodemographic and Occupation-Related Characteristics
2012 2013 2014
Characteristics APRa (95% CI) APR (95% CI) APR (95% CI)
Age group (years)
  18–49 1.40 (0.33, 2.47) 1.98 (0.57, 3.40) 1.45 (0.57, 2.33)
  50–64 1.03 (0.29, 1.78) 1.54 (0.41, 2.66) 1.33 (0.45, 2.21)
  ≥65 ref ref ref
Race/ethnicity
  Non-Hispanic, white only ref ref ref
  Non-Hispanic, black only 0.78 (0.49, 1.06) 0.73 (0.49, 0.97) 0.79 (0.55, 1.03)
  Hispanic 0.98 (0.62, 1.33) 0.75 (0.48, 1.02) 0.98 (0.69, 1.27)
  Non-Hispanic, other or multiple races 1.00 (0.59, 1.40) 0.98 (0.52, 1.43) 0.97 (0.64, 1.30)
Educational status
  Some college education or less 1.22 (0.67, 1.77) 1.21 (0.68, 1.74) 1.02 (0.52, 1.53)
  Associate/bachelor’s degree 0.69 (0.36, 1.02) 0.69 (0.46, 0.91) 0.80 (0.56, 1.05)
  Beyond college degree ref ref ref
Poverty statusb
  Below poverty 0.97 (0.72, 1.21) 0.81 (0.62, 0.99) 0.90 (0.68, 1.12)
  Above poverty ref ref ref
Occupation categories
  Physician ref ref ref
  Nurse practitioner/physician assistant 1.12 (0.85, 1.39) 1.19 (0.87, 1.51) 1.23 (0.93, 1.53)
  Nurse 0.92 (0.67, 1.17) 1.18 (0.83, 1.54) 1.08 (0.78, 1.39)
  Other clinical personnelc 0.81 (0.56, 1.07) 0.85 (0.63, 1.08) 0.87 (0.63, 1.11)
  Non-clinical personneld 0.53 (0.24, 0.83) 0.61 (0.34, 0.88) 0.60 (0.38, 0.82)
Occupational settings ref
  Hospital ref ref
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2012 2013 2014
Characteristics APRa (95% CI) APR (95% CI) APR (95% CI)
  Ambulatory care/physician’s office 1.29 (0.97, 1.61) 0.95 (0.71, 1.18) 0.90 (0.64, 1.17)
  Long-term care facility 0.83 (0.49, 1.16) 0.54 (0.29, 0.79) 0.63 (0.35, 0.91)
  Other settingse 1.27 (0.73, 1.80) 0.73 (0.43, 1.03) 1.25 (0.91, 1.58)
Contact with an infant aged ≤6 months
  Yes 1.51 (1.11, 1.92) 1.22 (0.89, 1.55) 1.42 (1.10, 1.74)
  No ref ref ref
Employment
  Direct hire ref ref ref
  Licensed independent practitioner 0.75 (0.39, 1.12) 0.88 (0.54, 1.21) 0.98 (0.66, 1.31)
  Contract employee 0.92 (0.57, 1.27) 1.06 (0.74, 1.38) 0.88 (0.59, 1.18)
Influenza vaccination in current season
  Yes 1.69 (1.10, 2.28) 1.17 (0.84, 1.51) 1.27 (0.87, 1.68)
  No ref ref ref
Employer policy for flu vaccination
  Yes 1.17 (0.86, 1.47) 1.22 (0.91, 1.54) 1.21 (0.94, 1.49)
  No ref ref ref
Note: Boldface indicates statistical significance (p < 0.05 comparing to reference group).
aAdjusted prevalence ratios, adjusted for all variables included in the table. Missing data for Tdap vaccination status for respondents who answered 
that they were vaccinated with tetanus vaccine since 2005 but either were not told by their doctor or were not sure which type of tetanus vaccine 
they received were imputed using multiple imputation under the missing-at-random assumption. Other variables with missing data, such as poverty, 
employment status, employer policy for influenza vaccination, age, contact with an infant ≤6 months, occupation, and occupational setting, were 
also imputed using this method. Estimates of Tdap vaccination were calculated with imputed data when responses to one or more questions were 
unknown. Imputations were done using the logistic regression Fractional Conditional Specification multiple imputation method, with age group, 
race/ethnicity, education, poverty, occupation, occupational setting, contact with an infant ≤6 months, employment status, influenza vaccination 
status, and employer policy for influenza vaccination as predictors, generating 10 imputed data sets. Tdap vaccination coverage proportion and the 
adjusted prevalence ratio, based on the predictive marginal under the multivariable logistic regression model, was calculated for each imputed data 
set and corresponding variances and covariances were calculated using two-way cross tabulations and logistic regression analysis, respectively. The 
results from the 10 imputed data sets were combined for overall inferences, accounting for variability between imputations.
b
Poverty status was defined based on the reported number of people and children living in the household and annual household income, and the 
U.S. Census poverty thresholds (www.census.gov/data/tables/time-series/demo/income-poverty/historical-poverty-thresholds.html). As determined 
by the U.S. Census Bureau, for the 2014–2015 season below poverty = total family income of < $24,008 for a family of four with two minors as of 
2014; for the 2013–2014 season below poverty = total annual family income of < $23,624 for a family of four with two minors as of 2013; for the 
2012–2013 season below poverty = total annual family income of < $23,283 for a family of four with two minors as of 2012.
cAllied health professionals, technicians, and technologists.
dAdministrative support staff members or manager and nonclinical support staff members (including food service workers, laundry workers, 
janitors, and members of the housekeeping and maintenance staffs).
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e
Dentist office or dental clinic, pharmacy, laboratory, public health setting, healthcare education setting, emergency medical services setting, or 
other setting where clinical care or related services was provided to patients.
APR, adjusted prevalence ratios; Tdap, tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine.
Am J Prev Med. Author manuscript; available in PMC 2018 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Srivastav et al. Page 18
Ta
bl
e 
4
Se
ns
iti
v
ity
 A
na
ly
sis
 o
f T
da
p 
Va
cc
in
at
io
n 
Co
v
er
ag
e,
 H
ea
lth
ca
re
 P
er
so
nn
el
 In
te
rn
et
 P
an
el
 S
ur
ve
y,
 
20
12
–2
01
4,
 U
.S
.
A
pr
il 
20
12
 su
rv
ey
A
pr
il 
20
13
 su
rv
ey
A
pr
il 
20
14
 su
rv
ey
Se
ns
iti
v
ity
a
n
a
ly
sis
Sa
m
pl
e
siz
e,
 n
%
 v
a
cc
in
at
ed
(95
%
 C
I)
Sa
m
pl
e
siz
e,
 n
%
 v
a
cc
in
at
ed
(95
%
 C
I)
Sa
m
pl
e
siz
e,
 n
%
 v
a
cc
in
at
ed
(95
%
 C
I)
O
ve
ra
ll 
Td
ap
 v
ac
ci
na
tio
n
2,
03
8
34
.8
 (3
0.6
, 3
9.0
)
1,
61
3
40
.2
 (3
6.1
, 4
4.4
)
1,
63
3
42
.4
 (3
8.7
, 4
6.0
)
 
 
Lo
w
er
 b
ou
nd
a
2,
03
8
29
.1
 (2
5.9
, 3
2.3
)
1,
61
3
33
.6
 (3
0.1
, 3
7.2
)
1,
63
3
35
.0
 (3
1.7
, 3
8.4
)
 
 
U
pp
er
 b
ou
nd
b
2,
03
8
48
.4
 (4
4.7
, 5
2.1
)
1,
61
3
51
.3
 (4
7.5
, 5
5.2
)
1,
63
3
56
.0
 (5
2.4
, 5
9.6
)
a A
ll 
ex
cl
ud
ed
 re
sp
on
de
nt
s (
tho
se 
wh
o a
ns
we
red
 m
y d
oc
tor
 di
d n
ot 
say
 or
 no
t s
ure
 to
 th
e q
ue
sti
on
 ab
ou
t th
e t
yp
e o
f t
eta
nu
s v
ac
ci
na
tio
n 
re
ce
iv
ed
) w
ere
 as
su
me
d t
o b
e u
nv
ac
ci
na
te
d 
w
ith
 T
da
p 
va
cc
in
at
io
n.
b A
ll 
ex
cl
ud
ed
 re
sp
on
de
nt
s (
tho
se 
wh
o a
ns
we
red
 m
y d
oc
tor
 di
d n
ot 
say
 or
 no
t s
ure
 to
 th
e q
ue
sti
on
 ab
ou
t th
e t
yp
e o
f t
eta
nu
s v
ac
ci
na
tio
n 
re
ce
iv
ed
) w
ere
 as
su
me
d t
o b
e v
ac
ci
na
te
d 
w
ith
 T
da
p 
va
cc
in
at
io
n.
Td
ap
, t
et
an
us
 to
xo
id
, r
ed
uc
ed
 d
ip
ht
he
ria
 to
xo
id
, a
nd
 a
ce
llu
la
r p
er
tu
ss
is 
va
cc
in
e.
Am J Prev Med. Author manuscript; available in PMC 2018 October 01.
